Indefinite Delivery Contract 36E79726D0007
Award Date 5/10/26
Last Date to Order 5/9/27
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- This single-award Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals Inc. for the supply of Montelukast NA Tablets. The contract has a 1-year base period with four 1-year option periods, for a total potential period of performance through May 9, 2026. The contract ceiling value is $23,863,543.01. The contract aims to provide an uninterrupted source of Montelukast NA Tablets in various package...
- This single-award Indefinite Delivery Contract, issued by the Department of Veterans Affairs National Acquisition Center on May 30, 2026, establishes a supply agreement with Xlcare Pharmaceuticals Inc. (UEI: MEAUS5WHBJJ7) for the provision of Allopurinol Tablets to multiple federal agencies including the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract carries a ceiling value of $17,786,862.00 and...
- Avkare LLC was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center for the supply of Montelukast HCL Chewable Tablets, a leukotriene receptor antagonist commonly used in the treatment of asthma and allergic rhinitis. The contract, valued at $5.72 million with an ultimate completion date of August 8, 2026, was awarded on August 9, 2021, following a pre-solicitation opportunity posted on February 17, 2021. The base year...
- Jubilant Cadista Pharmaceuticals Inc. has been awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center for the supply of Lamotrigine Immediate Release Tablets. The contract, valued at approximately $11.9 million, was awarded on June 16, 2025, with an ordering period extending through June 15, 2026, followed by four one-year option periods that could extend the contract through June 15, 2030. The procurement is unrestricted with no...
- This indefinite delivery contract represents a single-award procurement executed on May 13, 2023, by the National Acquisition Center, a civilian federal agency, to supply Lacosamide injections to the U.S. government. The prime contractor, Xlcare Pharmaceuticals Inc. (UEI: MEAUS5WHBJJ7), is a minority-owned, small disadvantaged business and economically disadvantaged woman-owned small business certified entity. The contract carries a ceiling value of $761,850.00 and encompasses a base ordering...
- Marlex Pharmaceuticals Inc., a Delaware-based minority-owned small disadvantaged business, was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center on April 28, 2024, for the procurement and supply of Ezetimibe 10 mg tablets. The contract carries a ceiling value of $14,155,681.05 and covers a one-year base period from April 28, 2024, through April 27, 2025, with four additional one-year option periods extending through April 27,...
- Xlcare Pharmaceuticals Inc. was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center to supply Levetiracetam Tablets across multiple dosage strengths (250mg, 500mg, 750mg, and 1,000mg) and package configurations (60, 120, and 500 tablets per bottle). The contract, valued at $9,568,740.75, was awarded on May 24, 2026, with an ordering period from February 5, 2026 through May 23, 2026, followed by four one-year option periods...
- This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business that is certified as an economically disadvantaged woman-owned small business. The contract has a total ceiling value of $3,129,016.00 and a period of performance from November 16, 2020 to November 15, 2025. It is a single-award IDC that allows for the ordering of various pharmaceutical products...
- This single-award Indefinite Delivery Contract, valued at $9.55 million with an ultimate completion date of August 25, 2027, was awarded by the Defense Logistics Agency's Medical Supply Chain division to Mylan Pharmaceuticals Inc. on August 26, 2022. The contract encompasses the manufacture and distribution of pharmaceutical products classified under the Federal Supply Classification code 4610093699. As the prime contractor, Mylan Pharmaceuticals Inc. (UEI: NDN1MYB8DKK5), a registered for-profit...
- This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business certified as an economically disadvantaged woman-owned small business. The single-award IDC has a ceiling value of $28,973,375.80 and a base period of one year from June 26, 2022 to June 25, 2023, with four one-year option periods. The contract is for the supply of delayed-release pantoprazole...